Medical Communications

Cancer Research UK has announced that its subsidiary, Cancer Research Technology (CRT), and Celgene have agreed a drug discovery collaboration. …

Just 10 days away from Christmas, and big news is still flowing in the industry. Sanofi remains embroiled in scandal …

When Kare Shultz decided to take on the CEO position at Teva he would have known that he was setting …

Novartis has announced that the President of its oncology business, Bruno Strigini, is to retire next year, citing personal reasons …

Bristol-Myers Squibb has once again struck a deal with Ono Pharmaceutical for multiple programs, seeking to discover a boost to …

Pharmafile.com sat down with Dr Rav Seeruthun, Medical Director of Roche UK, to discuss his career thus far and the lessons …

The fight against the growth of antibiotic resistance has become a major talking point internationally in recent years and the …

Shortly following its announcement of Philippe Mazas as Chief Information Officer, Mundipharma has revealed it has appointed Alberto Martinez as …

The FDA has taken action on Coco Loko and Legal Lean Syrup, both made by Arco Globus Trading LLC, after …

In the latest addition to a number of high profile exits from Teva, previous interim Chief Executive and the company’s …

Exscientia, an Oxford-based drug design firm which has made headlines this year for its collaboration with GlaxoSmithKline to leverage its …

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …

Bob Kerslake, now former chair of King’s College hospital, London, has handed in his resignation, citing the lack of long-term …

Despite us nearing the end of the year, the news has not been slowing down at all. Headlines across Europe …

When Roche announced that its combination treatment of Tecentriq, alongside its own drug Avastin and chemotherapy, successfully extended progression-free survival …